Vliyanie glimepirida (Amarila) na sostoyanie lipidnogo obmena, perekisnoe okislenie lipidov i insulinrezistentnost'
https://doi.org/10.14341/2072-0351-6157
Abstract
About the Authors
Mikhail Ivanovich BalabolkinKafedra endokrinologii i diabetologii
A V Kravchenko
Kafedra endokrinologii i diabetologii
O G Kozlova
Kafedra endokrinologii i diabetologii
Elena Michailovna Klebanova
Kafedra endokrinologii i diabetologii
Viktoriya Michailovna Kreminskaya
Kafedra endokrinologii i diabetologii
Galina Grigor'evna Mamaeva
Kafedra endokrinologii i diabetologii
References
1. Muller G., Y. Satoh, К. Geisen.//Diabetes Research and Clinical Practice, 1995: 28 Suppl., SI 15-SI37.
2. Muller G. // Molecular Medicine, 2000, 6; 1 1: 907-933.
3. UK Prospective Diabetes Study (UKPDS) Group. // Lancet. 1998; 352: 837-853.
Review
For citations:
Balabolkin M.I., Kravchenko A.V., Kozlova O.G., Klebanova E.M., Kreminskaya V.M., Mamaeva G.G. Vliyanie glimepirida (Amarila) na sostoyanie lipidnogo obmena, perekisnoe okislenie lipidov i insulinrezistentnost'. Diabetes mellitus. 2003;6(3):20-24. (In Russ.) https://doi.org/10.14341/2072-0351-6157

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).